I started working at MediChem Life Sciences, a drug discovery and technology company, in a finance role when I graduated from college. deCODE Genetics acquired MediChem three years later, and I stayed on as vice president of finance at the Icelandic company’s U.S. office. Later, I became chief financial officer of Emerald Bio when the company spun out from deCODE in 2009, and I continue to hold this role at Beryllium. I have a bachelor’s degree in accounting from Eastern Illinois University.
I am both a true competitor and a consummate team player with everything I take on. I believe a team is always stronger than an individual. This should not come as a surprise, as I am also a sports fanatic. I enjoy watching and playing almost any sport, and I am an avid follower of the Chicago Cubs and Bears. I bring both a strong level of loyalty and a love of a good deal to my role as chief financial officer. I have been with Beryllium – and the company’s forbears – for more than 15 years, collectively, making me the longest-serving member of the team. My role has evolved over the years; I started my career as an entry-level accountant and worked my way up the proverbial ladder.